Literature DB >> 12470862

Protection against gp120-induced neurotoxicity by an array of estrogenic steroids.

Ilona Zemlyak1, Sheila M Brooke, Robert M Sapolsky.   

Abstract

gp120, the coat protein of HIV, can be neurotoxic and is thought to contribute to AIDS-related dementia complex. Such toxicity involves activation of glutamate receptors, mobilization of free cytosolic calcium, and generation of oxygen radicals. We have previously shown that the estrogen 17beta-estradiol, in concentrations of 100 nM or higher, lessens the neurotoxicity of gp120 in hippocampal and cortical cultures, blunts gp120-induced calcium mobilization, and lessens the oxidative consequences. In this study, we examined the protective potential of other estrogens. We found gp120 neurotoxicity in hippocampal cultures to be significantly lessened by estrone, equilin and estriol, although with an order of magnitude less potent than 17beta-estradiol. We also found all four estrogens to blunt gp120-induced calcium mobilization, with estriol being more efficacious than the other three estrogens. These findings give insight both into the mechanisms of estrogenic protection (e.g. receptor-dependent versus independent actions) as well as into the potential therapeutic use of estrogens against AIDS-related dementia complex. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470862     DOI: 10.1016/s0006-8993(02)03558-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Immune modulation by estrogens: role in CNS HIV-1 infection.

Authors:  Melinda E Wilson; Filomena O Dimayuga; Janelle L Reed; Thomas E Curry; Carol F Anderson; Avindra Nath; Annadora J Bruce-Keller
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.

Authors:  Joshua S Talboom; Elizabeth B Engler-Chiurazzi; Paul Whiteaker; Alain R Simard; Ronald Lukas; Jazmin I Acosta; Laszlo Prokai; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2010-09-19       Impact factor: 3.587

3.  Cigarette smoke and nicotine effects on behavior in HIV transgenic rats.

Authors:  Walter Royal; Joseph Bryant; Harry Davis; Ming Guo
Journal:  Behav Brain Res       Date:  2021-09-20       Impact factor: 3.352

4.  Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model.

Authors:  Aakifa Ahmad; Divya Vohora
Journal:  Neurol Sci       Date:  2014-04-19       Impact factor: 3.307

5.  5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.

Authors:  Jason J Paris; ShiPing Zou; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Brain Behav Immun       Date:  2016-01-13       Impact factor: 7.217

6.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 7.  Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models.

Authors:  Heather A Bimonte-Nelson; Jazmin I Acosta; Joshua S Talboom
Journal:  Molecules       Date:  2010-08-31       Impact factor: 4.411

8.  Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism.

Authors:  Sherie L Kendall; Caroline F Anderson; Avindra Nath; Jadwiga Turchan-Cholewo; Cantey L Land; Charles F Mactutus; Rosemarie M Booze
Journal:  BMC Neurosci       Date:  2005-06-08       Impact factor: 3.288

9.  HIV neurotoxicity: potential therapeutic interventions.

Authors:  David R Wallace
Journal:  J Biomed Biotechnol       Date:  2006

10.  Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia.

Authors:  Sam Iskander; Kimberley A Walsh; Robert R Hammond
Journal:  J Neuroinflammation       Date:  2004-05-27       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.